|25th January 2021||Jeffrey E. Eberwein||938||Open or private purchase||$13.01||$12,203.38|
|22nd January 2021||Jeffrey E. Eberwein||371||Open or private purchase||$13.38||$4,963.98|
|21st January 2021||Jeffrey E. Eberwein||1,000||Open or private purchase||$13.65||$13,650.00|
|15th January 2021||Jeffrey E. Eberwein||1,330||Open or private purchase||$11.36||$15,108.80|
|31st December 2020||Jeffrey E. Eberwein||3,498||Grant/award etc.||$0.00|
|30th November 2020||David J. Noble||3,000||Open or private sale||$2.97||$8,910.00|
|19th November 2020||Jeffrey E. Eberwein||7,866||Open or private purchase||$2.46||$19,350.36|
|18th November 2020||Jeffrey E. Eberwein||12,134||Open or private purchase||$2.52||$30,577.68|
|9th November 2020||David J. Noble||1,916||Exercise of derivative||$0.00|
|27th October 2020||Dimitrios Angelis||12,387||Grant/award etc.||$2.22||$27,499.14|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
Digirad Corp. engages in the provision of mobile healthcare solutions. It operates through the following segments: Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging. The Mobile Healthcare segment provides contract diagnostic imaging, including computerized tomography, magnetic resonance imaging, positron emission tomography and healthcare expertise to hospitals. The Diagnostic imaging segment develops solid-state gamma cameras, imaging systems and camera maintenance contracts.